Model 1 | Model 2 | Model 3 | Model 4 | Model 5 | Model 6 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Nagelkerke R Square | 14.0 % | 14.1 % | 20.6 % | 31.3 % | 34.5 % | ||||||
ORa (CI) | ORa (CI) | Changeb | ORa (CI) | Changeb | ORa (CI) | Changeb | ORa (CI) | Changeb | Changeb | ||
Age | |||||||||||
0–65 years | 1 | 1 | 1 | 1 | 1 | 1 | |||||
66–75 years | 1.88 (1.40–2.52) | 1.85 (1.38–2.49) | −1.6 % | 1.82 (1.36–2.45) | −3.2 % | 1.96 (1.45–2.65) | +4.3 % | 1.92 (1.38–2.65) | +2.1 % | 1.90 (1.36–2.65) | +1.1 % |
76–85 years | 5.10 (3.88–6.71) | 4.94 (3.74–6.52) | −3.1 % | 4.84 (3.67–6.40) | −5.1 % | 5.38 (4.03–7.18) | +5.5 % | 5.28 (3.86–7.21) | +3.5 % | 4.77 (3.47–6.57) | −6.5 % |
86 + years | 11.30 (7.82–16.34) | 10.88 (7.50–15.78) | −3.7 % | 10.70 (7.37–15.55) | −5.3 % | 13.17 (8.92–19.45) | +16.5 % | 14.46 (9.58–21.81) | +28 % | 13.30 (8.74–20.24) | +17.7 % |
Gender | |||||||||||
Women | 1.15 (0.94–1.40) | 1.18 (0.97–1.43) | +2.6 % | 1.24 (1.01–1.52) | +7.8 % | 1.24 (1.00–1.53) | +7.8 % | 1.14 (0.92–1.43) | −0.87 % | ||
Stroke previous year | |||||||||||
Yes | – | 2.05 (1.46–2.87) | 2.18 (1.54–3.09) | +0.1 % | 1.95 (1.35–2.83) | −4.8 % | 1.75 (1.19–2.55) | −14.6 % | |||
Stroke subtype | |||||||||||
TIA | – | 1 | 1 | 1 | |||||||
Ischaemic | – | 2.8 (2.20–3.57) | 1.59 (1.21–2.07) | −43.2 % | 1.48 (1.13–1.95) | −47.1 % | |||||
Hemor. | – | 6.01 (4.16–8.67) | 3.39 (2.28–5.03) | −43.6 % | 2.92 (1.95–4.37) | −51.4 % | |||||
Diagnoses | |||||||||||
Aphasia | – | – | 1.39 (1.12–1.74) | 1.41 (1.13–1.77) | +1.4 % | ||||||
Dysphagia | – | – | 6.83 (4.70–9.90) | 5.34 (3.63–7.86) | −21.8 % | ||||||
Hemiparesis | – | – | 1.82 (1.44–2.28) | 1.85 (1.46–2.33) | +1.65 % | ||||||
Diabetes | – | – | 1.50 (1.19–1.88) | 1.43 (1.13–1.80) | −4.7 % | ||||||
Geriatric multi-morbidity | |||||||||||
0 and 1 | – | – | – | – | 1 | ||||||
2 | – | – | – | – | 2.35 (1.81–3.04) | ||||||
3 | – | – | – | – | 3.08 (2.13–4.47) | ||||||
4+ | – | – | – | – | 3.53 (2.04–6.10) |